|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,307.00 JPY | -1.30% |
|
-5.43% | +6.19% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,084B 6.88B 5.97B 5.57B 5.12B 9.68B 655B 9.78B 65.67B 25.67B 327B 25.84B 25.27B | P/E 2027 * |
15.2x | P/E 2028 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 884B 5.61B 4.87B 4.54B 4.17B 7.89B 534B 7.98B 53.53B 20.93B 267B 21.06B 20.6B | EV / Sales 2027 * |
1.94x | EV / Sales 2028 * | 1.88x |
| Free-Float |
80.98% | Yield 2027 * |
3.4% | Yield 2028 * | 3.36% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -1.30% | ||
| 1 week | -5.43% | ||
| Current month | -3.23% | ||
| 1 month | -4.63% | ||
| 3 months | -0.37% | ||
| 6 months | -4.33% | ||
| Current year | +6.19% |
| 1 week | 2,287 |  | 2,514.5 |
| 1 month | 2,287 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | -5.43% | +40.59% | -13.01% | 7.01B | |
| +0.03% | -0.49% | +20.51% | +72.13% | 49.43B | |
| +4.48% | +6.09% | +61.10% | +128.42% | 38.54B | |
| -0.98% | +3.59% | -2.85% | +25.23% | 12.5B | |
| +0.80% | +1.97% | +19.07% | +76.56% | 11.73B | |
| +2.50% | -0.57% | +30.73% | +130.67% | 9.09B | |
| +0.17% | +2.31% | +15.24% | +34.04% | 6.86B | |
| -0.22% | +1.32% | +7.60% | +180.88% | 6.6B | |
| +2.65% | +2.28% | -33.70% | +9.41% | 5.48B | |
| +0.32% | +4.11% | +30.79% | +104.76% | 4.6B | |
| Average | +0.85% | +1.20% | +18.91% | +74.91% | 15.18B | |
| Weighted average by Cap. | +1.32% | +0.83% | +27.87% | +84.21% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 455B 2.89B 2.51B 2.34B 2.15B 4.06B 275B 4.1B 27.54B 10.77B 137B 10.84B 10.6B | 445B 2.82B 2.45B 2.28B 2.1B 3.97B 268B 4.01B 26.93B 10.53B 134B 10.6B 10.36B |
| Net income | 71.42B 453M 394M 367M 337M 638M 43.12B 645M 4.33B 1.69B 21.55B 1.7B 1.66B | 62.78B 398M 346M 323M 296M 560M 37.9B 567M 3.8B 1.49B 18.95B 1.5B 1.46B |
| Net Debt | -200B -1.27B -1.1B -1.03B -946M -1.79B -121B -1.81B -12.14B -4.75B -60.48B -4.78B -4.67B | -248B -1.58B -1.37B -1.28B -1.17B -2.22B -150B -2.24B -15.04B -5.88B -74.91B -5.92B -5.79B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | JP¥2,307.00 | -1.30% | 2,047,600 |
| 26-08-03 | JP¥2,337.50 | -1.95% | 1,775,600 |
| 26-07-31 | JP¥2,384.00 | -2.99% | 3,274,400 |
| 26-07-30 | JP¥2,457.50 | -1.36% | 1,852,100 |
| 26-07-29 | JP¥2,491.50 | +3.08% | 2,326,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
